Ancestry (3)
- ANC_PC1 - Ancestry PC1 (phv00560281.v1.p1)
- ANC_PC2 - Ancestry PC2 (phv00560282.v1.p1)
- ANC_PC3 - Ancestry PC3 (phv00560283.v1.p1)
Anthropometry (1)
- BMIZ - Age and sex standardized body mass index (BMI) z score (phv00560270.v1.p1)
Biomarkers (5)
- EOS - Blood eosinophil count (EOS) (phv00560274.v1.p1)
- EOS - Percent of eosinophils (phv00560301.v1.p1)
- LYMPHO - Percent of lymphocytes (phv00560302.v1.p1)
- MACRO - Percent of macrophages (phv00560300.v1.p1)
- NEUTRO - Percent of neutrophils (phv00560299.v1.p1)
Demographics (3)
- AGE - Subject age (phv00560269.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00560292.v1.p1)
- SEX - Biological sex (phv00560262.v1.p1)
Disease Events (7)
- ALLERGIC_ASTHMA - Allergic asthma (phv00560275.v1.p1)
- ALLERGIC_RHINITIS - Allergic rhinitis. Rhinitis diagnosed based on symptoms (runny nose, stuffy nose, and sneezing). Allergic rhinitis based on presence of rhinitis in addition to allergic sensitization at age 10. (phv00560280.v1.p1)
- ASTHMA_2 - Asthma definition 2: Parent-reported physician diagnosis of asthma plus a parental report of 1 or more wheezing episodes in the past 12 months. (phv00560284.v1.p1)
- ATOPY_SPT - Proportion of positive skin prick tests (phv00560271.v1.p1)
- FENO - Fractional exhaled nitric oxide (FeNO) (phv00560272.v1.p1)
- IGE - Total serum immunoglobulin E (IgE) (phv00560273.v1.p1)
- NON_ALLERGIC_ASTHMA - Non-allergic asthma (phv00560276.v1.p1)
Race and Ethnicity (1)
- RACE - Parent-reported race and ethnicity (phv00560268.v1.p1)
Respiratory (3)
- FEV1 - Forced expiratory volume in 1 second (FEV1) (phv00560277.v1.p1)
- FEV1/FVC - FEV1/FVC ratio (phv00560279.v1.p1)
- FVC - Forced vital capacity (FVC) (phv00560278.v1.p1)
Study Administration (1)
- COHORT - Name of cohort (phv00560285.v1.p1)
Other (25)
- ANALYTE_TYPE - Analyte type (phv00560290.v1.p1)
- ANALYTE_TYPE - Analyte type (phv00560305.v1.p1)
- ARRAY - Array or Sentrix ID (phv00560295.v1.p1)
- BASENAME - Basename (phv00560293.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00560289.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00560304.v1.p1)
- CIL_EPI - Percent ciliated epithelial cells (phv00560297.v1.p1)
- CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body. (phv00560261.v1.p1)
- DNA_CONC - DNA concentration (phv00560296.v1.p1)
- GEO_ACCESSION - GEO accession ID (GSM#) (phv00560287.v1.p1)
- IS_TUMOR - Tumor status (phv00560291.v1.p1)
- IS_TUMOR - Tumor status (phv00560306.v1.p1)
- PLATE - Plate (phv00560294.v1.p1)
- SAMPLE_ID - Sample ID (phv00560288.v1.p1)
- SAMPLE_ID - Sample ID (phv00560303.v1.p1)
- SAMPLE_ID - Sample ID (phv00560266.v1.p1)
- SAMPLE_ID - Sample ID (phv00560286.v1.p1)
- SOURCE_SUBJECT_ID - Subject source ID (phv00560264.v1.p1)
- SOURCE_SUBJECT_ID2 - Subject source ID (phv00560363.v1.p1)
- SQUAM - Percent squamous cells (phv00560298.v1.p1)
- SUBJECT_ID - Subject ID (phv00560267.v1.p1)
- SUBJECT_ID - Subject ID (phv00560260.v1.p1)
- SUBJECT_ID - Subject ID (phv00560265.v1.p1)
- SUBJECT_SOURCE - Subject source (phv00560263.v1.p1)
- SUBJECT_SOURCE2 - Subject source (phv00560362.v1.p1)